Tag: research

Research that we funded nearly 20 years ago laid the foundations for last week’s approval of dabrafenib and trametinib to treat childhood gliomas.

Peter Buckle is a patient advocate and has worked with several teams, including the ARISTOCRAT team to champion research and clinical trials.

Living with a lower-grade glioma has a profound impact on those diagnosed, and their families. This is well documented anecdotally but needs to be scientifically addressed so that everyone affected by a brain tumour diagnosis gets the help and support they need.

A new nanosurgical tool – about 500 times thinner than a human hair – could help us understand how glioblastomas become resistant to radio- and chemotherapy. Up until now, no other technology has been able to do this.

In 2019, we awarded £2.96 million to Professor Neil Carragher in collaboration with Cancer Research UK as part of £6 million of funding for vital research into glioblastoma.

Dr Veronica Rendo, a researcher funded by The Brain Tumour Charity, shared the findings of her work at the annual meeting of the Society for Neuro-Oncology.

We are pleased to announce that The Brain Tumour Charity has joined the Cancer Tech Accelerator 3.0 as a new funding partner!

Recent research suggests that there could be a new treatment on the horizon for some children diagnosed with low and high-grade gliomas.

Two of our funded researchers have won awards at the Society for Immunotherapy of Cancer (SITC) annual conference!

We recently attended the NICE 2023 conference and share some of the key takeaways we gathered from the event.

Natalie McKenna-Mounty was diagnosed with a glioblastoma in 2020, her tumour returned in June this year, and now she is supporting our new research funding to find better glioblastoma treatments.

We are pleased to announce the two researchers who have been awarded the Junior Fellowship grant – the second award in our Future Leaders programme!

Zachery Eckworth, now 11 years and living in Hampshire, was just 14 months old when we was diagnosed with an optic nerve glioma.

We are pleased to announce that we have awarded £4.5 million to three new, exciting research initiatives.

We praise the launch of OurBrainBank’s new policy report and share how it ties in with our research strategy and innovations around treatment for glioblastomas.

We’re driving forward cutting-edge research together, as the Foundation fulfils a ground-breaking new £1.5 million research grant 18 months early.

Researchers at the University of Toronto have identified a biomarker that can predict how aggressive meningiomas may be in those diagnosed with this type of brain tumour.

Experts at The Everest Centre are delivering a cutting-edge program of scientific research to develop pioneering new treatments for children diagnosed with low-grade brain tumours, following major new funding from The Brain Tumour Charity.

Offering coaching to promote healthy lifestyles could help reduce severe fatigue for patients following brain tumour treatment, a clinical trial has found.

The government has signed an agreement with German pharmaceutical company BioNTech to ensure their innovative vaccine research comes to England.

Researchers have found the origin of group 3 and 4 childhood medulloblastoma, which could help develop new treatments for children diagnosed with one of the most common forms of cancerous brain tumour.

New research suggests that ulixertinib may offer one of the first targeted therapies for the most common form of brain tumour in children.

A major phase III clinical trial has found that novel treatment DCVax®-L may prolong the lives of people diagnosed with a new or recurrent glioblastoma.

We are delighted to announce the appointment of the first-ever The Brain Tumour Charity Chair of Translational Neuro-Oncology at The University of Manchester’s Cancer Research Centre (MCRC).